These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27438849)

  • 1. Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.
    Teto G; Fonsah JY; Tagny CT; Mbanya D; Nchindap E; Kenmogne L; Fokam J; Njamnshi DM; Kouanfack C; Njamnshi AK; Kanmogne GD
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27438849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implications.
    Ronsard L; Lata S; Singh J; Ramachandran VG; Das S; Banerjea AC
    PLoS One; 2014; 9(1):e85452. PubMed ID: 24465566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans.
    Buttò S; Fiorelli V; Tripiciano A; Ruiz-Alvarez MJ; Scoglio A; Ensoli F; Ciccozzi M; Collacchi B; Sabbatucci M; Cafaro A; Guzmán CA; Borsetti A; Caputo A; Vardas E; Colvin M; Lukwiya M; Rezza G; Ensoli B;
    J Infect Dis; 2003 Oct; 188(8):1171-80. PubMed ID: 14551888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon.
    Zhao J; Tang S; Ragupathy V; Gaddam D; Wang X; Zhang P; Nyambi PN; Hewlett I
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):344-50. PubMed ID: 22549382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 ((HIV-1) subtypes in the northwest region, Cameroon.
    Abongwa LE; Nyamache AK; Torimiro JN; Okemo P; Charles F
    Virol J; 2019 Aug; 16(1):103. PubMed ID: 31416460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring HIV-1 Group M Subtypes in Yaoundé, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG/F2 Infection.
    Courtney CR; Agyingi L; Fokou A; Christie S; Asaah B; Meli J; Ngai J; Hewlett I; Nyambi PN
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):381-5. PubMed ID: 26681241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection.
    Niyasom C; Horthongkham N; Sreephiang A; Kantakamalakul W; Louisirirotchanakul S; Chuenchitra T; Sutthent R
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):748-58. PubMed ID: 19842409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersubtype Genetic Variation of HIV-1 Tat Exon 1.
    Roy CN; Khandaker I; Oshitani H
    AIDS Res Hum Retroviruses; 2015 Jun; 31(6):641-8. PubMed ID: 25748226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Leukocyte Antigen-Associated HIV-1 CRF02_AG gag and vif Polymorphisms in Ghana.
    Adusei-Poku MA; Matsuoka S; Bonney EY; Abana CZ; Duker EO; Nii-Trebi NI; Ofori SB; Mizutani T; Ishizaka A; Shiino T; Kawana-Tachikawa A; Ishikawa K; Ampofo WK; Matano T
    Jpn J Infect Dis; 2019 Nov; 72(6):374-380. PubMed ID: 31257246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of Indian HIV-1 nef: subtyping, variability and implications.
    Jere A; Tripathy S; Agnihotri K; Jadhav S; Paranjape R
    Microbes Infect; 2004 Mar; 6(3):279-89. PubMed ID: 15026015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.
    Tongo M; Zembe L; Ebong E; Roux S; Bekker LG; Williamson C; Mpoudi-Ngole E; Burgers WA
    Vaccine; 2014 Apr; 32(20):2328-36. PubMed ID: 24598726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional domains of the human immunodeficiency virus type 1 Nef protein are conserved among different clades in Cameroon.
    Ndjomou J; Zekeng L; Kaptue L; Däumer M; Kaiser R; Matz B; Kupfer B
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):936-44. PubMed ID: 17067262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants.
    Mullick R; Sengupta S; Sarkar K; Chakrabarti S
    Virus Res; 2010 Feb; 147(2):195-201. PubMed ID: 19896991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa.
    Vidal N; Diop H; Montavon C; Butel C; Bosch S; Ngole EM; Touré-Kane C; Mboup S; Delaporte E; Peeters M
    Infect Genet Evol; 2013 Mar; 14():73-82. PubMed ID: 23232100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
    Saina MC; Bi X; Lihana R; Lwembe R; Ishizaki A; Panikulam A; Palakudy T; Musoke R; Owens M; Songok EM; Ichimura H
    PLoS One; 2015; 10(8):e0137140. PubMed ID: 26317223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of the nef gene from human immunodeficiency virus type 1 group M strains representing genetic subtypes A, B, C, E, F, G, and H.
    Jubier-Maurin V; Saragosti S; Perret JL; Mpoudi E; Esu-Williams E; Mulanga C; Liegeois F; Ekwalanga M; Delaporte E; Peeters M
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):23-32. PubMed ID: 10024049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.
    Rossenkhan R; MacLeod IJ; Sebunya TK; Castro-Nallar E; McLane MF; Musonda R; Gashe BA; Novitsky V; Essex M
    J Virol; 2013 May; 87(10):5732-45. PubMed ID: 23487450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of individual's T-cell immunome in controlling HIV-1 progression.
    Grifoni A; Montesano C; Palma P; Giovanetti M; Castelli-Gattinara G; Ciccozzi M; Mattei M; Mancino G; Salerno A; Colizzi V; Amicosante M
    Immunology; 2014 Dec; 143(4):631-9. PubMed ID: 24954875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159).
    Lazaro E; Tram LT; Bellecave P; Guidicelli GL; Anies G; Thu HH; Debelleix MP; Vray M; Recordon-Pinson P; Taupin JL; Lien TT; Fleury H
    PLoS One; 2011; 6(10):e26244. PubMed ID: 22039450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.